Jiangsu Lanfeng Bio-chemical Co Ltd Total Liabilities
Jiangsu Lanfeng Bio-chemical Co Ltd total liabilities. Based on the latest financial reports, Jiangsu Lanfeng Bio-chemical Co Ltd (002513) has total liabilities worth CN¥3.80 Billion CNY (≈ $555.47 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 002513 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Jiangsu Lanfeng Bio-chemical Co Ltd (2007–2025)
Total liabilities of Jiangsu Lanfeng Bio-chemical Co Ltd from 2007 to 2025. This chart illustrates how Jiangsu Lanfeng Bio-chemical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 002513 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Jiangsu Lanfeng Bio-chemical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangsu Lanfeng Bio-chemical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Virginia National Bankshares Corp
NASDAQ:VABK
|
USA | $1.46 Billion |
|
AerSale Corp
NASDAQ:ASLE
|
USA | $268.39 Million |
|
Ulusoy Elektrik Imalat
IS:ULUSE
|
Turkey | TL7.13 Billion |
|
Cathay Consolidated Inc
TW:1342
|
Taiwan | NT$1.57 Billion |
|
Apeejay Surrendra Park Hotels Limited
NSE:PARKHOTELS
|
India | Rs7.12 Billion |
|
India Glycols Limited
NSE:INDIAGLYCO
|
India | Rs35.90 Billion |
|
Vimta Labs Limited
NSE:VIMTALABS
|
India | Rs-4.57 Billion |
|
Ace Pillar Co Ltd
TW:8374
|
Taiwan | NT$2.83 Billion |
Liability Composition Analysis (2007–2025)
This chart breaks down Jiangsu Lanfeng Bio-chemical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Jiangsu Lanfeng Bio-chemical Co Ltd balance sheet assets.
Liquidity & Leverage Metrics
Jiangsu Lanfeng Bio-chemical Co Ltd Total Liabilities Ratios Explained
Jiangsu Lanfeng Bio-chemical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 761.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.93 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Lanfeng Bio-chemical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Lanfeng Bio-chemical Co Ltd (2007–2025)
The table below shows the annual total liabilities of Jiangsu Lanfeng Bio-chemical Co Ltd from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥4.12 Billion ≈ $603.16 Million |
+32.70% |
| 2024-12-31 | CN¥3.11 Billion ≈ $454.54 Million |
-1.36% |
| 2023-12-31 | CN¥3.15 Billion ≈ $460.79 Million |
+181.67% |
| 2022-12-31 | CN¥1.12 Billion ≈ $163.59 Million |
+5.34% |
| 2021-12-31 | CN¥1.06 Billion ≈ $155.30 Million |
-7.80% |
| 2020-12-31 | CN¥1.15 Billion ≈ $168.45 Million |
-26.55% |
| 2019-12-31 | CN¥1.57 Billion ≈ $229.35 Million |
-16.17% |
| 2018-12-31 | CN¥1.87 Billion ≈ $273.61 Million |
+24.72% |
| 2017-12-31 | CN¥1.50 Billion ≈ $219.38 Million |
-2.60% |
| 2016-12-31 | CN¥1.54 Billion ≈ $225.24 Million |
-5.37% |
| 2015-12-31 | CN¥1.63 Billion ≈ $238.02 Million |
+11.25% |
| 2014-12-31 | CN¥1.46 Billion ≈ $213.96 Million |
+4.28% |
| 2013-12-31 | CN¥1.40 Billion ≈ $205.18 Million |
+21.93% |
| 2012-12-31 | CN¥1.15 Billion ≈ $168.27 Million |
+87.87% |
| 2011-12-31 | CN¥612.09 Million ≈ $89.57 Million |
+6.06% |
| 2010-12-31 | CN¥577.14 Million ≈ $84.45 Million |
+40.21% |
| 2009-12-31 | CN¥411.64 Million ≈ $60.24 Million |
+46.63% |
| 2008-12-31 | CN¥280.73 Million ≈ $41.08 Million |
-7.26% |
| 2007-12-31 | CN¥302.71 Million ≈ $44.30 Million |
-- |
About Jiangsu Lanfeng Bio-chemical Co Ltd
Jiangsu Lanfeng Bio-chemical Co.,Ltd engages in the production and processing of fungicide, insecticide, herbicide technicals and formulations, and chemical products in China and internationally. It offers carbendazim, thiophanate, fluticasone, benzoyl, cymoxanil, iprodione, imidacloprid, acetamiprid, pyrethroid, pyridaben, butylene, acetaminophen, lego, cycloazine, thiophanate-methyl, butylcarbo… Read more